Abstract
Optic neuritis is a sudden inflammation of the optic nerve (ON) and is marked by pain on eye movement, and visual symptoms such as a decrease in visual acuity, color vision, contrast and visual field defects. The ON is closely linked with multiple sclerosis (MS) and patients have a 50% chance of developing MS within 15 years. Recent advances in multi-atlas segmentation methods have omitted volumetric assessment. In the past, measuring the size of the ON has been done by hand. We utilize a new method of automatically segmenting the ON to measure the radii of both the ON and surrounding cerebrospinal fluid (CSF) sheath to develop a normative distribution of healthy young adults. We examine this distribution for any trends and find that ON and CSF sheath radii do not vary between 20–35 years of age and between sexes. We evaluate how six patients suffering from optic neuropathy compare to this distribution of controls. We find that of these six patients, five of them qualitatively differ from the normative distribution which suggests this technique could be used in the future to distinguish between optic neuritis patients and healthy controls.
Keywords: Multi-Atlas Segmentation, Magnetic Resonance Imaging, Optic Nerve, Non-linear Optimization
1. INTRODUCTION
The size of the optic nerve (ON) and surrounding cerebrospinal fluid (CSF) have been manually measured[1, 2] previously and have been suggested as a differential diagnosis[3]. Optic neuritis is a sudden inflammation of the ON and is marked by pain on eye movement, and visual symptoms such as a decrease in visual acuity, color vision, contrast and visual field defects [4]. The ON is closely linked with multiple sclerosis (MS) and patients have a 50% chance of developing MS within 15 years [5]. Despite this, there is no radiological biomarker of the ON that predicts eventual development of MS. Furthermore, interventions can now help preserve and/or restore visual function if administered before ON axons are lost, i.e., during the ‘neuroplasticity’ window [6–8]. We hope to better understand ON disease etiology (including MS) using MRI to examine the ON anatomy along the length of the nerve as illustrated in Figure 1.
Figure 1.

Comparison of the ON of a healthy control (A) and an MS patient with severe ON atrophy (B). Red lines in the axial images show the location of the coronal slices to the right.
Manual segmentation with “computer assistance” has been and remains the de facto standard process to characterize the ON on 3-D imaging. Hickman et al. used contouring to identify ON cross-sections in a longitudinal analysis and revealed patterns consistent with acute inflammation followed by long-term atrophy [9, 10]. Combined conventional and magnetization transfer (MT) imaging studies using manual contouring of the ON volume have shown that ON degeneration is associated with persistent functional deficits [11]. These studies have focused on ROIs consisting of the whole ON rather than tract-localized findings. MRI has recently been shown to be accurate at measuring the ON and the CSF sheath using manual observers [12]. Recent efforts have also attempted to automatically segment the ON in MRI but did not segment the sheath or apply to their tool to diseased patients [13]. Recently, we have proposed multi-atlas segmentation pipelines for both CT [14] and MRI[15]. The CSF sheath is not differentiable from the nerve on CT, which is why we choose to focus this effort on MRI.
The goal of this work is to develop a normative distribution of controls using an automated tool to measure the size of the ON and cerebrospinal fluid (CSF) sheath independently for comparison against patient populations. We also present a feasibility study which demonstrates that patient populations may differ from the derived normative distributions which suggests that this technique could be used for differentiating different populations in the future.
2. METHODOLOGY
Our segmentation begins with a previously described multi-atlas segmentation method [14] which automatically segments the orbits, optic chiasm and ON. This method uses 35 manually labeled atlas images which include both healthy controls as well as optic nerve drusen and MS patients. The target image to be segmented is registered to each of the 35 atlas images using an affine registration and non-rigid registration [16]. The manual labels of the atlas images are then transformed to the target space using these registrations and are fused using non-local spatial STAPLE[17, 18]. The segmentation of the ON includes both the ON and CSF sheath and so we must refine our segmentation to separate the two structures and measure them independently.
We utilize a previously described model [19] which can be seen in Equation (1) to fit the ON and CSF sheath in the coronal plane and extract the radii of both. The model is a difference of two Gaussian distributions which matches the intensity profile of the ON in the coronal plane. The second Gaussian is scaled by an exponential term and has a scaling factor on the covariance matrix in the range (0,1) such that the second Gaussian is always smaller than the first Gaussian. The covariance matrix is formulated with the correlation term as a sigmoid function to improve stability later on, during the optimization process.
| (1) |
| (2) |
| (3) |
We define the error as the sum of squared difference between the model and the image which can be seen in Equation (4). The derivative can be seen in Equation (5) where the last term is the partial derivative with respect to each of the eight model parameters. These partial derivatives are computed analytically and can be seen in Equations (6)(7)(8)(9)(10)(11). Note that the derivatives for σy and μy are omitted as they are a direct substitutions into equations (6) and (9), respectively. In summary, the complete model is composed of eight terms: Θ = [σx, σy, σ2, I0, μx, μy, β, ρ].
We then fit the model to the ON in the coronal plane using an iterative conjugate gradient descent optimization method on all eight parameters [20].
| (4) |
| (5) |
| (6) |
| (7) |
| (8) |
| (9) |
| (10) |
| (11) |
The model parameters are correlated with the radii of the ON and CSF sheath through a random forest regression[21] using 1.2 million synthetic training images. Six of the eight model parameters are used for the regression, the centroids are omitted as they are dependent solely on field of view. These training images were generated by simulating partial volume effects of imaging two concentric tubular structures with 0.6 mm isotropic voxels using a Monte Carlo simulation. This model is then tilted at varying angles relative to the imaging plane and the size of each of the concentric tubes is varied to generate the training set. The regression is validated using tenfold cross validation which shows the predicted radii to correlate with the true underlying radii with an explanatory R-squared greater than 0.95 for both ON and sheath radii.
3. DATA
3.1 Data acquisition
MRI images were obtained with heavily T2-weighted VISTA 3-D spin echo with asymmetric k-space turbo spin echo readout, TR=4s TE=400ms, nominal resolution = 0.6 mm isotropic, ~50 axial slices, SENSE = 2, body coil excitation, and 32 channel receive coil on a 3T Philips Achieva MRI (Philips Medical Systems, Best, The Netherlands). Total scan time was 4.3 min and the field of view included the full optic nerves from the globe to the lateral geniculate nucleus (LGN).
3.2 Demographic Information
Our control population consists of 45 individuals which are young adults with good representation of both male and female subjects. Six relapsing remitting MS patients with optic neuritis were selected to have the worst binocular 1.25% contrast visual acuity to assess whether they were different from the normative distribution.
3.3 Model Application
The model is initialized using the result of a previously described multi-atlas segmentation protocol [14]. Iterative conjugate gradient descent is performed on each slice which contains ON labels from the multi-atlas protocol. Each slice’s optimal parameters are then used in the random forest regression to predict the true underlying radii of the ON and CSF sheath. The results are analyzed along the length of the ON. To make this comparison we interpolate every set of ON measurements to be the same number of samples as the longest one in the data set. The nature of the ONs allows for them to be present in a different number of slices from volume to volume. Interpolation more closely aligns corresponding parts of the ON across subjects. A three-element moving window median filter is also applied within each nerve across slices to reduce noise in the measurements.
4. RESULTS & DISCUSSION
4.1 Normative Distribution Evaluation
Using this framework we examined the normative distribution of controls as a function of normalized length posterior to the globe. Variations in the distribution based on this age range and sex information were investigated and found to be nonexistent. Figure 2 shows the similarity of the distributions across both age and sex. This suggests that although the ON varies widely among healthy controls the variation is not dependent upon age or sex of the subject over this limited age range.
Figure 2.
ON radius with error bars as the standard deviation as a function of normalized slice posterior to the globe illustrating the similarity of distributions regardless of age and sex among the 45 healthy controls.
4.2 Patient Evaluation
We then compare the six selected patients to the normative distribution to see if irregularities became apparent. We would expect patients to fall outside of the normal distribution and it can be seen in Figure 3 that most of them do. From Figure 3 patient 1’s ON appears to be smaller than the normative distribution around the midsection of the ON. This would suggest that this nerve is atrophic while the sheath appears to be approximately of normal size. The star indicates that this slice is shown for comparison in Figure 4 against an age matched control in the first column. The comparison in Figure 4 matches what is observed in the measurements from Figure 3. The sheath appears to be of a similar radius to the age matched control’s sheath while the nerve appears slightly atrophic. Patient 2 appears slightly atrophic through the anterior part of the ON and we see inflammation in the posterior of the ON in both eyes. Patient 3 displays atrophy in both eyes in the anterior region. The right eye remains atrophic for the length of the ON while the left eye appears to approach the normative distribution. Patient 4 appears closest to the normative distribution although the right eye does appear to be slightly atrophic in some regions. Patient 5 shows atrophy in the right ON while the left ON appears highly inflamed. The stars again mark slices which can be seen in Figure 4 for comparison against an age matched control. In this comparison it is very clear the ON is much larger than that of the age matched control. Patient 6 appears atrophic in both eyes with the left being more severe. Once again Figure 4 shows a selected slice and it is clear that the ON is smaller in this patient when compared to the age matched control. These results show promise for this method as a possible tool to differentiate patient and control populations.
Figure 3.
Measurements for the six selected patients as their left and right ONs compare to the normative distribution. Note the asterisks which mark the approximate locations of the visuals from Figure 4.
Figure 4.
Selected comparisons of 3 patients and age matched healthy controls. Patients 1 and 6 are atrophic and patient 5 is hypertrophic.
4.3 Conclusions
We have presented a method for quantitatively measuring the ON and the CSF sheath and have demonstrated its feasibility as a possible tool for differentiating patients with ON atrophy or hypertrophy from healthy subjects. Although this population of healthy control subjects contains a large amount of inter-subject variation the small comparison of patients suggests that there may be information which differs within patients from the normative distribution. This differentiation requires further investigation with a larger patient population to fully understand how patients with varying conditions compare across the length of the ON.
All tools used and developed in this work are available in open source from their respective authors. The tools that implement the ON specific components of analysis are based on the Java Image Science Toolkit (JIST)[22] and NonLocal STAPLE [18]. The ON/sheath characterization code is primarily written in MATLAB (The MathWorks, Inc., Natick, Massachusetts, United States) and bundled into an automated program (i.e., “spider”[23]) that combines these tools using PyXNAT[24] for XNAT[25] and is available in open source through the NITRC project MASIMATLAB (http://www.nitrc.org/projects/masimatlab).
Table 1.
Age demographic information for the 45 controls and six patients
| Controls: 45 | Patients: 6 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 20–25 | 25–30 | 30–35 | Over 35 | Total | 20–25 | 25–30 | 30–35 | Over 35 | Total | |
| Male | 5 | 12 | 3 | 1 | 21 | 0 | 0 | 1 | 0 | 1 |
| Female | 11 | 1 | 10 | 2 | 24 | 1 | 1 | 3 | 0 | 5 |
| Total | 16 | 13 | 13 | 3 | 45 | 1 | 1 | 4 | 0 | 6 |
Acknowledgments
Research reported in this publication was supported by the National Eye Institute of the National Institutes of Health under Award Numbers R21EY024036, R01EY023240 and by the National Institutes of Health under Award Number 5T32EY007135. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. This project was supported by ViSE/VICTR VR3029. The project described was supported by the National Center for Research Resources, Grant UL1 RR024975-01, and is now at the National Center for Advancing Translational Sciences, Grant 2 UL1 TR000445-06. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. This work was conducted in part using the resources of the Advanced Computing Center for Research and Education at Vanderbilt University, Nashville, TN.
References
- 1.Repka MX, Quigley HA. The effect of age on normal human optic nerve fiber number and diameter. Ophthalmology. 1989;96(1):26–32. doi: 10.1016/s0161-6420(89)32928-9. [DOI] [PubMed] [Google Scholar]
- 2.Newman W, Hollman A, Dutton G, et al. Measurement of optic nerve sheath diameter by ultrasound: a means of detecting acute raised intracranial pressure in hydrocephalus. British journal of ophthalmology. 2002;86(10):1109–1113. doi: 10.1136/bjo.86.10.1109. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Gerling J, Janknecht P, Hansen LL, et al. Diameter of the optic nerve in idiopathic optic neuritis and in anterior ischemic optic neuropathy. International ophthalmology. 1997;21(3):131–135. doi: 10.1023/a:1026422819404. [DOI] [PubMed] [Google Scholar]
- 4.Richa C. The Neuro-Ophthalmology Survival Guide. Optometry-Journal of the American Optometric Association. 2010;81(9):423–424. [Google Scholar]
- 5.Group ONS. Multiple sclerosis risk after optic neuritis: final optic neuritis treatment trial follow-up. Archives of neurology. 2008;65(6):727. doi: 10.1001/archneur.65.6.727. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Beck RW, Cleary PA, Anderson MM, Jr, et al. A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. The Optic Neuritis Study Group. N Engl J Med. 1992;326(9):581–8. doi: 10.1056/NEJM199202273260901. [DOI] [PubMed] [Google Scholar]
- 7.Minen MT, Karceski S. Multiple sclerosis and disease-modifying therapies. Neurology. 2011;77(4):e26. doi: 10.1212/WNL.0b013e318229e6ca. [DOI] [PubMed] [Google Scholar]
- 8.Zhang K, Zhang L, Weinreb RN. Ophthalmic drug discovery: novel targets and mechanisms for retinal diseases and glaucoma. Nat Rev Drug Discov. 2012;11(7):541–59. doi: 10.1038/nrd3745. [DOI] [PubMed] [Google Scholar]
- 9.Hickman SJ, Toosy AT, Jones SJ, et al. A serial MRI study following optic nerve mean area in acute optic neuritis. Brain. 2004;127(Pt 11):2498–505. doi: 10.1093/brain/awh284. [DOI] [PubMed] [Google Scholar]
- 10.Hickman SJ, Brierley CM, Brex PA, et al. Continuing optic nerve atrophy following optic neuritis: a serial MRI study. Mult Scler. 2002;8(4):339–42. doi: 10.1191/1352458502ms809oa. [DOI] [PubMed] [Google Scholar]
- 11.Inglese M, Ghezzi A, Bianchi S, et al. Irreversible disability and tissue loss in multiple sclerosis: a conventional and magnetization transfer magnetic resonance imaging study of the optic nerves. Arch Neurol. 2002;59(2):250–5. doi: 10.1001/archneur.59.2.250. [DOI] [PubMed] [Google Scholar]
- 12.Steinborn M, Fiegler J, Kraus V, et al. High resolution ultrasound and magnetic resonance imaging of the optic nerve and the optic nerve sheath: anatomic correlation and clinical importance. Ultraschall in der Medizin-European Journal of Ultrasound. 2011;32(06):608–613. doi: 10.1055/s-0029-1245822. [DOI] [PubMed] [Google Scholar]
- 13.Yiannakas MC, Toosy AT, Raftopoulos RE, et al. MRI Acquisition and Analysis Protocol for In Vivo Intraorbital Optic Nerve Segmentation at 3T. Investigative ophthalmology & visual science. 2013;54(6):4235–4240. doi: 10.1167/iovs.13-12357. [DOI] [PubMed] [Google Scholar]
- 14.Harrigan RL, Panda S, Asman AJ, et al. Robust optic nerve segmentation on clinically acquired computed tomography. Journal of Medical Imaging. 2014;1(3):034006–034006. doi: 10.1117/1.JMI.1.3.034006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Panda S, Asman AJ, Khare SP, et al. Evaluation of Multi-Atlas Label Fusion for Orbital Segmentation on In Vivo MRI. Journal of Medical Imaging. 2014 doi: 10.1117/1.JMI.1.2.024002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Avants BB, Tustison NJ, Song G, et al. A reproducible evaluation of ANTs similarity metric performance in brain image registration. Neuroimage. 2011;54(3):2033–2044. doi: 10.1016/j.neuroimage.2010.09.025. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Asman AJ, Landman BA. Formulating Spatially Varying Performance in the Statistical Fusion Framework. Medical Imaging, IEEE Transactions on. 2012;31(6):1326–1336. doi: 10.1109/TMI.2012.2190992. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Asman AJ, Landman BA. Non-local statistical label fusion for multi-atlas segmentation. Med Image Anal. 2013;17(2):194–208. doi: 10.1016/j.media.2012.10.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Harrigan RL, Plassard AJ, Bryan FW, et al. Disambiguating the Optic Nerve from the Surrounding Cerebrospinal Fluid Sheath in MS-related Atrophy. Magnetic Resonance in Medicine. 2014 doi: 10.1002/mrm.25613. in press. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Nocedal J, Wright SJ. Conjugate gradient methods. Springer; 2006. [Google Scholar]
- 21.Breiman L, Friedman J, Stone CJ, et al. Classification and regression trees. CRC press; 1984. [Google Scholar]
- 22.Lucas BC, Bogovic JA, Carass A, et al. The Java Image Science Toolkit (JIST) for rapid prototyping and publishing of neuroimaging software. Neuroinformatics. 2010;8(1):5–17. doi: 10.1007/s12021-009-9061-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Gao Y, Burns SS, Lauzon CB, et al. Integration of XNAT/PACS, DICOM, and Research Software for Automated Multi-modal Image Analysis. Proc SPIE, 8674. 2013 doi: 10.1117/12.2007621. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Schwartz Y, Barbot A, Thyreau B, et al. PyXNAT: XNAT in Python. Front Neuroinform. 2012;6:12. doi: 10.3389/fninf.2012.00012. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Marcus DS, Olsen TR, Ramaratnam M, et al. The Extensible Neuroimaging Archive Toolkit: an informatics platform for managing, exploring, and sharing neuroimaging data. Neuroinformatics. 2007;5(1):11–34. doi: 10.1385/ni:5:1:11. [DOI] [PubMed] [Google Scholar]



